Dihydroquercetin: More than just an impurity?

European Journal of Pharmacology

Volumn 684, Issue 1-3, 2012, Pages 19-26

  Weidmann, Anita Elaine ^a  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

Antioxidant; Dihydroquercetin; Flavonoid; Quercetin; Silymarin; Taxifolin

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; ASTILBIN; CERULENIN; CHOLESTEROL; CYTOCHROME P450; EPIGALLOCATECHIN GALLATE; ERIODICTYOL; FATTY ACID SYNTHASE; FLAVONE DERIVATIVE; FLAVONOID; GLUTATHIONE TRANSFERASE A2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOXERUTIN; MYELOPEROXIDASE; POVIDONE; QUERCETIN; REACTIVE NITROGEN SPECIES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SAKURANETIN; SILYMARIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TAXIFOLIN; TETRAHYDROLIPSTATIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; CANCER INHIBITION; CARDIOVASCULAR DISEASE; CHOLESTEROL SYNTHESIS; DRUG ABSORPTION; DRUG BINDING SITE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETOXIFICATION; DRUG HALF LIFE; DRUG IMPURITY; DRUG POTENCY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TARGETING; HUMAN; LIVER DISEASE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; SINGLE DRUG DOSE; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CELL LINE, TUMOR; HUMANS; LIVER DISEASES; NEOPLASMS; QUERCETIN;

EID: 84860835972     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.03.035     Document Type: Review

References (104)

1. Agency for toxic substances and disease registry (ATSDR) Toxicological Profile for Benzidine 1995 US Public Health Services, US Department of Health and Human Services Atlanta, GA
2. P.L. Alo, P. Visca, A. Marci, A. Mangoni, C. Botti, and U. Ditondo Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients Cancer 77 1996 474 482 (Pubitemid 26047568)
3. J. Antosiewicz, W. Ziolkowski, S. Kar, A.A. Powolny, and S.V. Singh Role of reactive oxygen intermediated in cellular responses to dietary cancer chemopreventive agents Planta Med. 74 2008 1570 1579
4. S.C. Bischoff Quercetin: potentials in the prevention and therapy of disease Curr. Opin. Clin. Nutr. Metab. Care 11 2008 733 740
5. M. Blumenthal, and W.R. Busse The Complete German Commission E. Monographs: Therapeutic Guide to Herbal Medicines 1998 American Botanical Council Austin, Tex
6. A.M. Boerboom, M. Vermeulen, H. van der Woude, B.I. Bremer, Y.Y. Lee-Hilz, E. Kampman, P.J. van Bladeren, M. Rietjens, and J. Aarts Newly constructed stable reporter cell lines for mechanistic studies on electrophile response element-mediated gene expression reveal a role for flavonoid planarity Biochem. Pharmacol. 72 2006 217 226 (Pubitemid 43880358)
7. A.N. Booth, and F. Deeds The toxicity and metabolism of dihydroquercetin J. Am. Pharm. Assoc. Am. Pharm. Assoc. (Baltim) 47 2006 183 184
8. L.H. Breimer Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage Mol. Carcinog. 3 1990 188 197 (Pubitemid 20335528)
9. K. Brusselmans, E. De Schriver, W. Heyns, G. Verhoeven, and J.V. Swinnen Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells Int. J. Cancer 106 2003 856 862 (Pubitemid 37071663)
10. K. Brusselmans, R. Vrolix, G. Verhoeven, and J.V. Swinnen Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity J. Biol. Chem. 280 2005 5636 5645 (Pubitemid 40280043)
11. A. Casaaschi, B.K. Rubio, G.K. Maiyoh, and A.G. Theriault Inhibitory activity of diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) by the flavonoid, taxifolin, in HepG2 cells: potential role in the regulation of apolipoprotein B secretion Atherosclerosis 176 2004 247 253 (Pubitemid 39369513)
12. J.W. Chen, Z.Q. Zhu, T.X. Hu, and D.Y. Zhu Structure-activity relationship of natural flavonoids in hydroxyl radical-scavenging effects Acta Pharmacol. Sin. 23 2002 667 672
13. G.M. Chisolm, and D. Steinberg The oxidative modification hypothesis of atherogenesis: an overview Free Radic. Biol. Med. 28 2000 1815 1826 (Pubitemid 30628668)
14. J.S. Choi, H.Y. Vhung, S.S. Kang, M.J. Jung, J.W. Kim, J.K. No, and H.A. Jung The structure-activity relationship of flavonoids as scavengers of peroxynitrite Phytother. Res. 16 2002 232 235 (Pubitemid 34534948)
15. M.C. Comelli, U. Mengs, C. Schneider, and M. Prosdocimi Toward the definition of mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy Integr. Cancer Ther. 6 2007 120 129 (Pubitemid 46871849)
16. M.J. Coon Cytochrome P450: nature's most versatile biological catalyst Annu. Rev. Pharmacol. Toxicol. 45 2005 1 25 (Pubitemid 40261796)
17. S.P. Davies, H. Reddy, M. Caivano, and P. Cohen Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochem. J. 351 2000 95 105
18. T. Ding, S. Tian, Z. Zhang, D. Gu, Y. Chen, Y. Shi, and Z. Sun Determination of active components in silymarin by RP-LC and LC/MS J. Pharm. Biomed. Anal. 26 2001 155 161 (Pubitemid 32635293)
19. D.J. Dorta, A.A. Pigoso, F.E. Mingatto, T. Rodrigues, I.M.R. Prado, A.F.C. Helena, A.A. Uyemura, A.C. Santo, and C. Curti The interaction of flavonoids with mitochondria: effects on energetic processes Chem. Biol. Interact. 152 2005 67 78 (Pubitemid 40517146)
20. EMEA, European Medicines Agency Public summary of opinion on orphan designation. Silibinin-C-2′,3-dihydrogensuccinate, disodium salt for the prevention of recurrent hepatitis C in liver transplant recipients. Doc. Ref. EMEA/COMP/642562/2010 Available at: http://www.ema.europa.eu/ema/index.jsp?curl= pages/medicines/human/orphans/2011/01/human-orphan-000877.jsp&mid= WC0b01ac058001d12b&murl=menus/medicines/medicines.jsp [Accessed: February 2012]
21. L.V. Favreau, and C.B. Pickett Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants J. Biol. Chem. 266 1991 2556 2561
22. N. Ferrara Vascular endothelial growth factor: molecular and biological aspects Curr. Top. Microbiol. Immunol. 237 1999 1 30 (Pubitemid 28554856)
23. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocrinol. Rev. 18 1997 4 25 (Pubitemid 27076453)
24. T.W. Flaig, D.L. Gustafson, L.J. Su, J.A. Zirrolli, F. Crighton, G.S. Harrison, A.S. Pierson, R. Agarwal, and L.M. Glodé A phase I and pharmacokinetic study of silybinin-phytosome in prostate cancer patients Invest. New Drugs 25 2007 139 146 (Pubitemid 46020872)
25. T.W. Flaig, L.M. Glodé, D. Gustafson, A. van Bokhoven, Y. Tao, S. Wilson, L.J. Su, Y. Li, G. Harrison, R. Agarwal, E.D. Crawford, M.S. Lucia, and M. Pollak A study of high-dose oral silybinin-phytosome followed by prostatectomy in patients with localized prostate cancer Prostate 70 2010 848 855
26. R. Flavin, S. Peluso, P.L. Nguyen, and M. Loda Fatty acid synthase as a potential therapeutic target in cancer Future Oncol. 6 2010 551 562
27. F. Franschini, G. Dermatini, and D. Esposti Pharmacology of silymarin Clin. Drug Investig. 22 2002 51 56
28. R.S. Frilling, A. Bensimon, Y. Tichauer, and V. Daniel Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element Proc. Natl. Acad. Sci. U. S. A. 87 1990 6258 6262
29. E. Furuta, S.K. Pai, R. Zhan, S. Bandyopadhyay, M. Watabe, Y.Y. Mo, S. Hirota, S. Hosobe, T. Tsukada, K. Miura, S. Kamada, K. Saito, M. Iiizumi, W. Liu, J. Ericsson, and K. Watabe Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1 Cancer Res. 68 2008 1003 1011 (Pubitemid 351278386)
30. A. Garcia-Lafuente, E. Guillamón, A. Villares, M.A. Rostagno, and J.A. Martínez Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease Inflamm. Res. 58 2009 537 552
31. J.P. Gaut, J. Byun, H.D. Tran, W.M. Lauber, J.A. Carroll, R.S. Hotchkiss, A. Belaaouaj, and J.W. Heinecke Myeloperoxidase produces nitrating oxidants in vivo J. Clin. Invest. 109 2002 1311 1319 (Pubitemid 34546895)
32. R. Gebhardt Variable influence of kaempferol and myricetin on in vitro hepatocellular cholesterol biosynthesis Planta Med. 69 2003 1071 1074 (Pubitemid 38223345)
33. F.P. Guengerich, and T. Shimada Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes Chem. Res. Toxicol. 4 1991 391 407
34. G. Hahn, H.D. Lehmann, N. Kurten, H. Uebel, and G. Vogel Recent flavonoid research Arzneim. Forsch. 18 1968 698
35. H. Haraguchi, Y. Mochida, S. Sakai, H. Amsuda, Y. Tamura, M. Mizutani, O. Tanaka, and W.H. Chou Protection against oxidative damage by dihydroflavonols in Engelhardtia chrysolepis Biosci. Biotechnol. Biochem. 60 1996 945 948 (Pubitemid 26311230)
36. R.A. Hiipakka, H.Z. Zhang, W. Dai, Q. Dai, and S. Liao Structure-activity relationship for inhibition of human 5 alpha-reductases by polyophenols Biochem. Pharmacol. 63 2002 1165 1176 (Pubitemid 34267032)
37. K. Igarashi, Y. Uchida, N. Murakami, K. Mizutani, and H. Masuda Effect of astilbin in tea processed from leaves of Engelhardtia chrysolepsis on the serum and liver lipid concentrations and on the erythrocyte and liver antioxidative enzyme activities of rats Biosci. Biotechnol. Biochem. 60 1996 513 515 (Pubitemid 126460942)
38. Y. Imumara, T. Kigita, Y. Uriu, M. Otagiri, and T. Okawara Inhibitory effects of flavonoids on rabbit heart carbonyl reductase J. Biochem. 127 2000 653 658 (Pubitemid 30238359)
39. P.D. Josephy Benzidine: mechanism of oxidative activation and mutagenesis Fed. Proc. 45 1986 2465 2470 (Pubitemid 16020680)
40. C. Kandaswami, E. Perkins, D.S. Soloniuk, G. Drzewiecki, and E. Middleton Jr. Antiproliferative effect of citrus flavonoids on a human squamous cell carcinoma in vitro Cancer Lett. 56 1991 147 152
41. C. Kandaswami, E. Perkins, G. Drzewiecki, D.S. Soloniuk, and E. Middleton Jr. Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblasts-like lung cells in culture by plant flavonoids Anticancer Drugs 3 1992 525 530
42. J.W. Kaspar, S.K. Niture, and A.K. Jaiswal Nrf2:INrf2 (Kep1) signalling in oxidative stress Free Radic. Biol. Med. 47 2009 1304 1309
43. E. Kiehlmann, and P.M. Edmond Isomerisation of dihydroquercetin J. Nat. Prod. 58 1995 450 455
44. N.C. Kim, T.N. Graf, C.M. Sparacino, M.C. Wani, and M.E. Wall Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum) Org. Biomol. Chem. 1 2003 1684 1689
45. V.A. Kostyuk, T. Kraemer, H. Sies, and T. Schewe Myeloperoxidase/nitrite- mediated lipid peroxidation of low-density lipoprotein as modulated by flavonoids FEBS Lett. 537 2003 146 150 (Pubitemid 36246692)
46. S.J. Kridel, W.T. Lowther, and I.V.C.W. Pemble Fatty acid synthase inhibitors: new directions for oncology Expert Opin. Investig. Drugs 16 2007 1817 1829 (Pubitemid 350187394)
47. P.M. Kris-Etherton, A.H. Lichtensetin, B.V. Howard, D. Steinberg, and J.L. Witztum Antioxidant vitamin supplements and cardiovascular disease Circulation 110 2010 637 641
48. D.J. Kroll, H.S. Shaw, and N.H. Oberlies Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies Integr. Cancer Ther. 6 2007 110 119 (Pubitemid 46871844)
49. E.F. Kurth, and F.L. Chan Dihydroquercetin as an antioxidant J. Am. Oil Chem. Soc. 28 1951 433 436
50. F. Kvasniča, B. Bíba, R. Ševčik, M. Voldřich, and J. Krátká Analysis of the active components of silymarin J. Chromatogr. A 990 2003 239 245 (Pubitemid 36293880)
51. J.D. Lambert, and R.J. Elias The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention Arch. Biochem. Biophys. 501 2010 65 72
52. S.B. Lee, K.H. Cha, D. Selenge, A. Solongo, and C.W. Nho The chemopreventative effect of taxifolin is exerted through ARE-dependent gene regulation Biol. Pharm. Bull. 30 2007 1074 1079 (Pubitemid 46883868)
53. B.H. Li, R. Zhang, Y.T. Du, Y.H. Sun, and W.X. Tian Inactivation mechanism of the beta-ketoacyl-[acyl carrier protein] reductase of bacterial type-II fatty acid synthase by epigallocatechin gallate Biochem. Cell Biol. 84 2006 755 762 (Pubitemid 46121600)
54. H. Luo, B.H. Jiang, S.M. King, and Y.C. Chen Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids Nutr. Cancer 60 2008 800 809
55. R. Lupu, and J.A. Mendez Targeting fatty acid synthase in breast cancer and endometrial cancer: an alternative to selective estrogen receptor modulators? Endocrinology 147 2006 4056 4066 (Pubitemid 44274975)
56. P.S. Makena, and K.T. Chung Effects of various plant polyphenols on bladder carcinogen benzidine-induced mutagenicity Food Chem. Toxicol. 45 2007 1899 1909 (Pubitemid 47238204)
57. K. Maruyama, Y. Mori, S. Murasawa, H. Masaki, N. Takahashi, Y. Tsutusmi, Y. Moriguchi, Y. Shibazaki, Y. Tanaka, M. Shibuya, M. Inada, H. Matsubara, and T. Iwasaka Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases J. Mol. Cell Cardiol. 31 3 1999 607 617 (Pubitemid 29121646)
58. T. Mashima, H. Seimiya, and T. Tsuruo De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy Br. J. Cancer 100 2009 1369 1372
59. T. Miura, S. Muraoka, and Y. Fujimoto Inactivation of creatine kinase induced by quercetin with horseradish peroxidase and hydrogen peroxide: pro-oxidative and anti-oxidative actions by quercetin Food Chem. Toxicol. 41 2003 759 765 (Pubitemid 36555881)
60. R. Moreno-Sánchez, S. Rodríguez-Enríquez, A. Marín-Hernández, and E. Saavedra Energy metabolism in tumor cells FEBS J. 274 2007 1393 1418 (Pubitemid 46333738)
61. M. Murata, A. Tamura, M. Tada, and S. Kawanishi Mechanism of oxidative DNA damage induced by carcinogenic 4-aminobiphenyl Free Radic. Biol. Med. 30 2001 765 773 (Pubitemid 32245582)
62. E.G. Nabel Cardiovascular disease N. Engl. J. Med. 349 2003 60 72 (Pubitemid 36765105)
63. E.E. Nifant'ev, M.P. Koroteev, G.Z. Kaziev, A.A. Uminskii, A.A. Grachev, V.M. Men'shov, Y.E. Tsvetkov, N.E. Nifant'ev, V.K. Bel'skii, and A.I. Stash On the problem of identification of the dihydroquercetin flavonoid Russ. J. Gen. Chem. 76 2006 161 163 (Pubitemid 44284482)
64. J.C. Pew A flavonone from Douglas-fir heartwood J. Am. Chem. Soc. 70 1948 3031
65. C.J. Piyathilake, A.R. Frost, U. Manne, W.C. Bell, H. Weiss, D.C. Heimburger, and W.E. Grizzle The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung Hum. Pathol. 31 2000 1068 1073
66. E.S. Pizer, J. Thupari, W.F. Han, M.L. Pinn, F.J. Chrest, G.L. Freywot, C.A. Townsend, and F.P. Kuhajda Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts Cancer Res. 60 2000 213 218 (Pubitemid 30070736)
67. M. Plísková, J. Vondrácek, V. Kren, R. Gazák, P. Sedmera, D. Walterová, J. Psotová, V. Simánek, and M. Machala Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation Toxicology 215 2005 80 89 (Pubitemid 41430276)
68. M.B. Plotnikov, O.I. Aliev, M.J. Maslov, A.S. Vasiliev, and N.A. Tjukavkina Correction of haemorheological disturbances in myocardial infarction by diquertin and ascorbic acid Phytother. Res. 17 2003 86 88 (Pubitemid 36205467)
69. S.J. Polyak, C. Morishima, V. Lohmann, S. Pal, D.Y.W. Lee, Y. Liu, T.N. Graf, and N.H. Oberlies Identification of hepatoprotective flavonolignans from silymarin PNAS 107 2010 5995 5999
70. O.N. Pozharitskaya, M.V. Karlina, A.N. Shikov, V.M. Kosman, M.N. Makarova, and V.G. Makarov Determination of pharmacokinetic study of taxifolin in rabbit plasma by high performance liquid chromatography Phytomedicine 16 2009 244 251
71. V.V. Rogozhin, and D.V. Peretolchin Kinetic regulation of dihydroquercetin oxidation with horseradish peroxide Russ. J. Bioorg. Chem. 35 2009 576 580
72. P. Rohdewald A review of the French maritime pine bark extract (pycnogenol), a herbal medication with a diverse clinical pharmacology Int. J. Clin. Pharmacol. Ther. 40 2002 158 168 (Pubitemid 34296383)
73. N. Salah, J. Miller, G. Paganga, L. Tijburg, G.P. Bolwell, and C. Rice-Evans Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants Arch. Biochem. Biophys. 322 1995 339 346
74. Y. Sawai, J.H. Moon, K. Sakata, and N. Watanabe Effects of structure on radical-scavenging abilities and antioxidative activities of tea polyphenols: NMR analytical approach using 1,1-Diphenyl-2-picrylhydrazyl radicals J. Agric. Food Chem. 53 2005 3598 3604 (Pubitemid 40758201)
75. G.L. Semenza Expression of hypoxia-inducible factor 1: mechanisms and consequences Biochem. Pharmacol. 59 2000 47 53
76. A. Seyoum, K. Asres, and F.K. El-Fiky Structure-activity scavenging activity relationships of flavonoids Phytochemistry 67 2006 2058 2070 (Pubitemid 44301284)
77. B. Shao, M.N. Oda, J.F. Oram, and J.W. Heinecke Myeloperoxidase: an oxidative pathway for generating dysfunctional High Density Lipoprotein Chem. Res. Toxicol. 23 2010 447 454
78. S.C. Shen, C.H. Ko, S.W. Tseng, S.H. Tsai, and Y.C. Chen Structurally related antitumor effects of flavanones in vitro and in vivo: involvement of caspase 3 activation, p21 gene expression, and reactive oxygen species production Toxicol. Appl. Pharmacol. 197 2004 84 95 (Pubitemid 38639899)
79. A.N. Shikov, O.N. Pozharitskaya, I. Miroshnyk, S. Mirza, I.N. Urakova, S. Hirsjärvi, V.G. Makarov, J. heinämäki, J. Yliruusi, and R. Hitunen Nanodispersions of taxifolin: impact of solid-state properties on dissolution behaviour Pharm. Nanotechnol. 377 2009 148 152
80. M.M. Silva, M.R. Santos, G. Caroco, R. Rocha, G. Justino, and L. Mira Structure-antioxidant activity relationship of flavonoids: a re-examination Free. Radic. Res. 36 2002 1219 1227 (Pubitemid 35230242)
81. R. Slimestad, T. Fossen, and I.M. Vagen Onions: a source of unique dietary flavonoids J. Agric. Food Chem. 55 2007 10067 10080
82. D. Steinberg Low density lipoprotein oxidation and its pathophysiological significance J. Biol. Chem. 272 1997 20963 20966 (Pubitemid 27373946)
83. R. Stocker, and J.F. Keaney Jr. Role of oxidative modifications in artherosclerosis Physiol. Rev. 84 2004 1381 1478
84. N. Sutandyo Nutritional carcinogenesis Acta Med. Indones. 42 2010 36 42
85. J.V. Swinnen, T. Roskams, S. Joniau, H. Van Poppel, R. Oven, L. Baert, W. Hevns, and G. Verhoeven Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer Int. J. Cancer 98 2002 19 22 (Pubitemid 34113412)
86. Y.O. Teselkin, I.V. Babenkova, V.K. Kolhir, A.L. Baginskaya, N.A. Tjukavkina, Y.A. Kolesnik, I.A. Selivanova, and A.A. Eichholz Dihydroquercetin as a means of antioxidative defence in rats with tetrachloromethane hepatitis Phytother. Res. 14 2000 160 162 (Pubitemid 30326007)
87. Iu.O. Teskin, B.A. Zhambalova, I.V. Babenkova, and N.A. Tiukavkina Antioxidant properties of dihydroquercetin Biofizika 41 1996 620 624
88. A. Theriault, Q. Wang, S.C. Van Iderstine, B. Chen, A.A. Franke, and K. Adeli Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid J. Lipid Res. 41 2000 1969 1979 (Pubitemid 32038992)
89. A. Triantafyllou, I. Mylonis, G. Simos, S. Bonanou, and A. Tsakalof Flavonoids induce HIF-1a but impair its nuclear accumulation and activity Free Radic. Biol. Med. 44 2008 657 670
90. Y. Uda, K.R. Price, G. Williamson, and M.J. Rhodes Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids Cancer Lett. 120 1997 213 216 (Pubitemid 27496819)
91. L.G. Valerio Jr., J.K. Kepa, G.V. Pickwell, and L.C. Quattroci HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/11275421" Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin Toxicol. Lett. 119 2001 49 57 (Pubitemid 32244058)
92. Y.A. Vladimirov, E.V. Proskurnina, E.M. Demin, N.S. Matveeva, O.B. Lubitskiy, A.A. Novikov, D.Y. Izmailov, O.N. Osipov, V.P. Tikhonov, and V.E. Kagan Dihydroquercetin (taxifolin) and other flavonoids as inhibitors of free radical formation at key stages of apoptosis Biochemistry (Mosc) 74 2009 301 307
93. I.V. Voskoboinikova, S.V. Tjukavkina, S.V. Geodakyan, Y.A. Kolesnik, V.K. Kolhir, A. Ziuzin, and S.J. Sokolov Experimental pharmacokinetics of biologically active plant phenolic compounds III. Pharmacokinetics of dihydroquercetin Phytother. Res. 7 2006 208 210
94. J. Wagoner, A. Negash, O.J. Kane, L.E. Martinez, Y. Nahmias, N. Bourne, D.M. Owen, J. Grove, C. Brimacombe, J.A. McKeating, E.L. Pécheur, and T.N. Graf Multiple effects of silymarin on the hepatitis C virus lifecycle Hepatology 51 2010 1912 1921
95. S.J. Wakil Fatty acid synthase, a proficient multifunctional enzyme Biochemistry 28 1989 4523 4530 (Pubitemid 19151020)
96. S.N. Wallace, D.J. Carrier, and E.C. Clausen Batch solvent extraction of flavonolignans from milk thistle (Silybum marianum L. Gaertner) Phytochem. Anal. 16 2005 7 16
97. G. Walldiu, I. Jungner, I. Holme, A.H. Aastveit, W. Kolar, and E. Steiner High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 2001 2026 2033 (Pubitemid 34084825)
98. X. Wang, and W. Tian Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase Biochem. Biophys. Res. Commun. 288 2001 1200 1206 (Pubitemid 33131728)
99. Y.H. Wang, W.Y. Wang, C. Chang, K.T. Liou, Y.J. Sung, J.F. Liao, C.F. Chen, S. Chang, Y.C. Hou, Y.C. Chou, and Y.C. Shen Taxifolin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-oxidative effect and modulation of NF-kappa b activation J. Biomed. Sci. 13 2006 127 141 (Pubitemid 43162511)
100. X.D. Wang, M.X. Meng, L.B. Gao, T. Liu, Q. Xu, and S. Zeng Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp Int. J. Pharm. 378 2009 1 8
101. O. Warburg On the origin of cancer cells Science 123 1956 309 314
102. W.W. Wasserman, and W.E. Fahl Functional antioxidant responsive elements Proc. Natl. Acad. Sci. 94 1997 5361 5366 (Pubitemid 27214788)
103. S. Yusuf, S. Hawken, S. Ounpuu, T. Dans, A. Avesum, F. Lanas, M. McQueen, A. Budaj, P. Pais, J. Varigos, L. Lisheng on behalf of the INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952 (Pubitemid 39208455)
104. V.P. Zherdev, G.B. Kolyvanov, A.A. Litvin, A.K. Sariev, A.O. Viglinskaia, B.I. Gekkiev, A.M. Grigor'ev, and V.V. Gorlov Comparative pharmacokinetics of dihydroquercetin in rats upon peroral administration of parent compound and liposomal flamen D Exp. Clin. Pharmacol. Eksperimentalnaya i klinicheskaya farmakoloogiya 73 2010 23 25